Use of point-of-care C-reactive protein testing for screening of tuberculosis in the community in high-burden settings: a prospective, cross-sectional study in Zambia and South Africa
The Lancet Global Health / May 2023
-- Accompanying comment: C-reactive protein: another addition to our armamentarium against tuberculosis?
********************
Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial
The Lancet Global Health / May 2023
-- Accompanying comment: Addressing the adherence challenge in tuberculosis treatment: more than digital technologies